---
$id: https://graph.org.ai/products/commodity/51392305
$type: Product
source: UNSPSC
code: "51392305"
title: "Debrisoquine sulfate"
class: "51392300"
classTitle: "Sympathomimetic or adrenergic isoquinolines and isoxazoles and naphthyridines and phenoxypropanolamines"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Debrisoquine sulfate

**UNSPSC Code**: 51392305
**Class**: [Sympathomimetic or adrenergic isoquinolines and isoxazoles and naphthyridines and phenoxypropanolamines](Sympathomimetic or adrenergic isoquinolines and isoxazoles and naphthyridines and phenoxypropanolamines.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic blocking agent with the molecular formula 2C10H13N3.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q94064N9NW, chemically known as 1,2,3, 4-tetrahydro-isoquinoline-2-carboxamidine sulfate but more generally known as debrisoquin sulfate, which bears US NIH Compound Identifier 2966. European Medicines Agency schedules Debrisoquine sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01567MIG. Most nations, for tariff and trade purposes, schedule debrisoquine sulfate under HS 29334990 and SITC 51575. SMILES: C1CCC2C(C1)CCN(C2)C(=N)N.C1CCC2C(C1)CCN(C2)C(=N)N.OS(=O)(=O)O.

